Comments on the study protocol: adjuvant treatment of mediastinitis with immunoglobulins (Pentaglobin) after cardiac surgery (ATMI).
Robicsek
F
F
The Carolinas Heart Institute, University of North Carolina, Charlotte, 28232-2861, USA.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001419:Bacteria / Q000145:classification; D006348:Cardiac Surgical Procedures / Q000009:adverse effects*; D006801:Humans; D007070:Immunoglobulin A / Q000627:therapeutic use*; D007075:Immunoglobulin M / Q000627:therapeutic use*; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008480:Mediastinitis / Q000145:classification / Q000382:microbiology / Q000517:prevention & control / Q000628:therapy*; D018579:Patient Selection; D012107:Research Design; D018401:Sample Size; D013530:Surgical Wound Infection / Q000145:classification / Q000382:microbiology / Q000517:prevention & control / Q000628:therapy; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D007070:Immunoglobulin A; D007075:Immunoglobulin M; D016756:Immunoglobulins, Intravenous; C060166:pentaglobulin